Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01844505
Brief Title: Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067)

First Submitted : April 29, 2013
First Submitted that Met QC Criteria : April 30, 2013
First Posted : May 1, 2013 (Estimate)

Results First Submitted : July 14, 2017
Results First Submitted that Met QC Criteria : August 28, 2017
Results First Posted : September 26, 2017

Last Update Submitted that Met QC Criteria : March 13, 2018
Last Update Posted : March 16, 2018